Daly K, Richardson P J, Bergman G, Atkinson L, Kerkez S, Jewitt D E
Br Heart J. 1984 Dec;52(6):628-32. doi: 10.1136/hrt.52.6.628.
The effects of timolol maleate administered intravenously on coronary and systemic haemodynamics, myocardial metabolism, and plasma catecholamine concentrations were assessed in 10 patients with confirmed coronary artery disease. Rapid atrial pacing to the onset of angina was performed in all patients. Timolol reduced cardiac output at rest and during pacing and reduced resting heart rate but did not affect arterial blood pressure. Left ventricular stroke work index fell during pacing. Coronary sinus blood flow was unchanged, but pulmonary artery diastolic pressure rose after timolol. The drug produced clinical improvement in nine of the 10 patients with prolongation of the mean pacing time to angina. There was evidence of improved myocardial metabolism with a change from production to extraction of lactate: Arterial noradrenaline concentrations at rest rose after timolol. In these patients with coronary artery disease timolol produced an increased tolerance to atrial pacing stress, which appears to be due to a combination of effects including reduced myocardial contractility and decreased lipolysis.
对10例确诊为冠状动脉疾病的患者评估了静脉注射马来酸噻吗洛尔对冠状动脉和全身血流动力学、心肌代谢及血浆儿茶酚胺浓度的影响。所有患者均进行快速心房起搏直至心绞痛发作。噻吗洛尔降低了静息及起搏时的心输出量,降低了静息心率,但不影响动脉血压。起搏期间左心室每搏功指数下降。冠状窦血流量未改变,但噻吗洛尔给药后肺动脉舒张压升高。该药物使10例患者中的9例临床症状改善,平均起搏至心绞痛发作的时间延长。有证据表明心肌代谢改善,乳酸从生成转变为摄取:静息时动脉去甲肾上腺素浓度在噻吗洛尔给药后升高。在这些冠状动脉疾病患者中,噻吗洛尔提高了对心房起搏应激的耐受性,这似乎是由于包括心肌收缩力降低和脂肪分解减少在内的多种效应共同作用的结果。